===
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons
closely associated with them
02.05.2024 / 17:40 CET/CEST
The issuer is solely responsible for the content of this announcement.
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name


Title: Dr.

First name: Thomas

Last name(s): von Planta
2. Reason for the notification a) Position / status


Position: Member of the administrative or supervisory body
b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name


BB BIOTECH AG
b) LEI


391200MBZQNPFHIVKO34
4. Details of the transaction(s) a) Description of the financial instrument, type of instrument, identification code


Type: Share

ISIN: CH0038389992
b) Nature of the transaction


Acquisition
c) Price(s) and volume(s)


Price(s) Volume(s)

41.45 CHF 24870.00 CHF

41.45 CHF 16580.00 CHF
d) Aggregated information


Price Aggregated volume

41.45 CHF 41450.00 CHF
e) Date of the transaction


30/04/2024; UTC+2
f) Place of the transaction


Name: SIX Swiss Exchange

MIC: XSWX

===
-----------------------------------------------------------------------------------------------------------------------

02.05.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.eqs-news.com

-----------------------------------------------------------------------------------------------------------------------

===

Language:     English 
Company:      BB BIOTECH AG 

Schwertstrasse 6
8200 Schaffhausen
Switzerland
Internet: www.bbbiotech.ch

End of News EQS News Service
===
91261 02.05.2024 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1894503&application_name=news

END) Dow Jones Newswires

May 02, 2024 11:40 ET (15:40 GMT)